Enteric Coating Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global enteric coating market is anticipated to grow at a significant CAGR of 3.9% during the forecast period (2022-2028). Enteric coating is a beneficial method for oral delivery of medications that rapidly break down in the stomach, such as insulin, since it prevents the drug from being released in the stomach’s acidic environment before reaching the intestine. The primary use of enteric coatings is to maintain the stability of APIs that are unstable when exposed to the acidic conditions of the gastrointestinal environment. Erythromycin, pancreatic, and proton pump inhibitors such as omeprazole are examples of APIs. The high incidence of gastric acidity in the stomach is driving the growth of the market. Additionally, the rising number of pharmaceutical drug developments is also supporting the growth of the market as some of these drugs have unique features such as protecting the stomach from the negative/irritating effects of tablet and capsule formulations.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance,

• In May 2021, Evonik has introduced the Eudracap capsule platform. According to the manufacturer, this is anenteric-coated pre-locked capsule that improves gastric resistance, intestinal absorption, and bioavailability.
• In July 2020, Colorcon, Inc. has introduced Acryl-EZE II, a new enteric coating that covers a wider pH range. Enteric-coated delays the release of drugs and protects the gastric mucosa from irritating activities, while additionally protecting medications that are unstable in gastric fluids. Colorcon’s Acryl-EZE II aqueous enteric system extends Colorcon’s line of aqueous enteric systems to provide specific applications for tablets and multiarticulate dosage forms with enhanced enteric protection up to a challenging pH 5.0, as seen in patients taking PPIs or when tested under fed conditions.
• In June 2019, Colorcon, Inc. has added new delayed-release coatings, Opadry Enteric to its pharmaceutical coatings range. The functional polymer hydroxypropyl methylcellulose phthalate (hypromellose phthalate or HPMC-P) is used in an innovative one-step film coating technique that provides enteric performance for hydro-alcoholic applications. When compared to multi-component coating systems, Opadry Enteric is a fully formulated one-step system that provides simple preparation and ease of use for film coating, resulting in reduced inventory and QC testing. The company’s existing Opadry delayed-release product line uses acrylic and PVAP polymers had now gota new alternative.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Shaoxing Kangke Capsule Co., Ltd., DuPont, BASF SE,  Purple Remedies Pvt. Ltd., and Colorcon Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Vegan Protein Bars Market Report by Segment

By Type

• Aqueous Based Coating
• Non-Aqueous Based Coating

By Application

• Health Supplements
• Pharmaceuticals
• Others